1. O4‐02‐01: PHASE 2A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM‐0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS. (1st July 2019) Authors: Boxer, Adam L.; Moebius, Hans; Harris, Baruch; Boeve, Bradley F.; Borroni, Barbara; van Swieten, John C.; Grossman, Murray; Pasquier, Florence; Frisoni, Giovanni B.; Mummery, Catherine J.; Vandenberghe, Rik; Le Ber, Isabelle; Hannequin, Didier; McGinnis, Scott M.; Auriacombe, Sophie; Onofrj, Marc... Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 23 Page Start: P1231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P3–285: Validation of a novel cognitive composite assessment for mild and prodromal Alzheimer's disease. (1st July 2013) Authors: Harrison, John; Dgetluck, Nancy; Gawryl, Maria; Moebius, Hans; Hilt, Dana Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 16 Page Start: P661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗